Latest Nicotinic agonists Stories

Varenicline reduces depressive mood, craving and reward value of cigarettes when smokers attempt to quit Smokers have a higher probability of quitting smoking and a better overall cessation experience when taking varenicline compared to bupropion and to placebo – unmedicated assisted smoking cessation –according to a study published in the journal JAMA Psychiatry. A team led by Paul Cinciripini, Ph.D., professor in the Department of Behavioral Science at The University of Texas MD...

A recent study from the Massachusetts General Hospital found a detectable level of the nicotine metabolite, cotinine, in 88% of non-smoking children and adults, indicating that they had been involuntarily exposed to tobacco smoke as a resident of the Boston Housing Authority. National estimates of second-hand smoke exposure, based on data from a previous CDC study were much lower. (PRWEB) January 31, 2013 Researchers from the Massachusetts General Hospital recently conducted a study of...

Alan McStravick for redOrbit.com - Your Universe Online Smoking rates among several target age groups have been in decline in the US. A new study of existing smokers focuses on their attempts at quitting and shows why there is a high likelihood those attempts will have been unsuccessful. Though there are several options available to smokers for cessation and ultimately for quitting outright, most smokers become frustrated and give up on quitting. Nancy Rigotti, MD, director of the...

Treatment Facility Puts State Law into Practice Early SEABROOK, N.J., Sept. 4, 2012 /PRNewswire-USNewswire/ -- Although a regulation to make all rehab facilities entirely smoke-free is still months away, Seabrook House has made its decision to be ahead of the curve and provide a truly drug-free environment for its patients starting today. "Seabrook House has earned its reputation for excellence in the treatment of adults suffering from alcoholism and drug addiction, and we pride...

Adults who are exposed to secondhand smoke have higher rates of obesity and Type 2 diabetes than do nonsmokers without environmental exposure to tobacco smoke, a new study shows. The results will be presented Sunday at The Endocrine Society's 94th Annual Meeting in Houston. "More effort needs to be made to reduce exposure of individuals to secondhand smoke," said study co-author Theodore C. Friedman, MD, PhD, chairman of the Department of Internal Medicine at Charles R. Drew University,...

An Extensive UCSF Study Questions Previous Study’s Analytic Methods San Francisco, CA (PRWEB) May 05, 2012 A popular smoking cessation medication has been under a cloud of suspicion ever since the Canadian Medical Association Journal (CMAJ) published a study in July 2011 reporting “risk of serious adverse cardiovascular events associated with varenicline.” Varenicline, also known as Chantix, blocks the pleasant effects of nicotine on the smoker’s brain and lessens nicotine...

An extensive UCSF study questions previous study's analytic methods A popular smoking cessation medication has been under a cloud of suspicion ever since the Canadian Medical Association Journal (CMAJ) published a study in July 2011 reporting "risk of serious adverse cardiovascular events associated with varenicline." Varenicline, also known as Chantix, blocks the pleasant effects of nicotine on the smoker's brain and lessens nicotine withdrawal symptoms. UCSF researchers, however,...

The smoking cessation drug varenicline significantly reduced alcohol consumption in a group of heavy-drinking smokers, in a study carried out by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco. “Alcohol abuse is a huge problem, and this is a big step forward in identifying a potential new treatment,” said senior author Howard L. Fields, MD, PhD, professor of neurology and director of the Wheeler Center for the Neurobiology of...

There is an association between the rs1051730-rs16969968 genotype and objective measures of tobacco exposure, which indicates that lung cancer risk is largely, if not entirely, mediated by level of tobacco exposure, according to a study published April 25 in the Journal of the National Cancer Institute. The rs1051730-rs16969968 genotype is known to be associated with heaviness of smoking, lung cancer risk, and other smoking-related outcomes. Prior studies have generally depended on...

MENLO PARK, Calif., March 14, 2012 /PRNewswire/ -- In preclinical studies, researchers at SRI International and Astraea Therapeutics have recently evaluated the role of a new drug receptor target that shows promise for the treatment of drug addiction. This potential new drug target belongs to a class of receptors called the nicotinic acetylcholine receptors (nAChRs). One subtype of nAChRs, called alpha4beta2, is a well-known target for nicotine's addictive effects and the...